SP
Seventure Partners
Venture CapitalActiveSeventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies.
196
Investments
7
Exits
$1B
AUM
3.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Seventure Partners.
Investment Thesis & Strategy
Seventure Partners invests in various stages of fintech, ICT, and IT companies, seeking innovative and high-growth businesses within the information and communication technology sectors.
Investment Activity
Deals per year over the last 11 years
1
20120
20133
20140
20150
20162
20172
20181
20190
20202
20211
2022Portfolio Companies
Selected investments from their portfolio of 196 companies
O
Omini
Healthcare · Series A, 2022
M
Mylia
Healthcare · Series A, 2021
A
Aledia
Other · Series C+, 2021
M
Microphyt
Cleantech · Series B, 2019
M
MaaT Pharma
Biotech · Series B, 2018
I
Inarix
Biotech · Series A, 2018
D
DNAlytics
Biotech · Series A, 2017
B
BioSerenity
Healthcare · Series B, 2017
G
Ginkgo Bioworks
Biotech · Series B, 2014
E
Enterome
Biotech · Series B, 2014
P
Pixium Vision
Biotech · Series C+, 2014
D
DBV Technologies
Biotech · Series C+, 2012
Notable Exits
CompanyTypeYearValue / Acquirer
BioSerenityAcquisition2023—
Truffle CapitalAcquisition2022—
Pixium VisionIPO2017—
SensorionIPO2016—
DBV TechnologiesIPO2014$360M
CarmatIPO2010—
Innate PharmaIPO2006—
Frequently Asked Questions
Seventure Partners focuses on Series A, Series B, Series C+ stage investments.